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Background.Darier’sdisease(DD),alsoknownasKeratosisFollicularisorDarier-Whitedisease,isararedisorderofkeratinization.
DD can present as a generalized autosomal dominant condition as well as a localized or segmental postzygotic condition (V´ azquez
etal.,2002).ClinicalfeaturesofDDincludegreasy,wartypapulesandplaquesonseborrheicareas,dystrophicnails,palmo-plantar
pits, and papules on the dorsum of the hands and feet. Objective. We report a case of basal cell carcinoma developing in a patient
with type 2 segmental DD. Conclusion. According to the current literature, Type 2 segmental disease is a rare presentation of
Darier’s disease with only 8 previous cases reported to date. In addition, nonmelanoma skin cancer (NMSC) arising from DD is
rarely reported; however, there may be an association between DD and risk of carcinogenesis.
1.Introduction
Darier’s disease (DD), also known as Keratosis Follicularis
or Darier-White disease, is a rare disorder of keratinization.
The disease is caused by a loss-of-function mutation in
the ATP2A2 gene on chromosome 12q23-24 that encodes
the sarco/endoplasmic reticulum calcium ATPase (SERCA2).
This loss of function leads to a disruption of Ca2+ home-
ostasiswithinthekeratinocytes,speciﬁcallydepletionofCa2+
stores in endoplasmic reticulum. Ultimately, the mutation
leads to impaired cell-to-cell adhesion with the common his-
tological ﬁndings of suprabasal acantholysis and dyskeratosis
of cells in the epidermis [1]. DD can present as a generalized
autosomal dominant condition as well as a localized or
segmental postzygotic condition [2]. Clinical features of DD
include greasy, warty papules and plaques on seborrheic
areas, dystrophic nails, palmo-plantar pits, and papules on
the dorsum of the hands and feet.
2. Observation
A 34-year-old woman with type 2 skin presented to clinic for
evaluation of a lesion in the left popliteal fossa that had been
present for approximately 1.5 years and frequently bled.
Past medical history was signiﬁcant for DD which was
diagnosed at 12 years of age. This was initially localized to
the left side of the body but over the previous ten years had
gradually become bilateral. She managed her disease with
only emollients and sun protection but as a teenager had
tried topical steroids, topical retinoids, and a short course of
accutane. She was otherwise well and not on any medication.
She denied a past history of excess sun exposure or blistering
burns. Neither of her two children or parents were aﬀected
by DD.
Examination revealed hundreds of erythematous to light
brown scaly 2-3mm diameter papules involving the head
and neck, trunk, and extremities. These formed large linear
plaques which were more prominent on the left half of
the body and followed Blaschko lines (Figures 1 and 2).
Similar acrokeratosis verruciformis-like warty papules as
well as larger verrucous papules and plaques were noted
on the dorsal hands and periungal areas. Several ﬁngernails
demonstrated longitudinal erythronychia and distal nicking
of the nail plate (Figure 3).
An erythematous shiny telangiectatic papule measuring
7mm in diameter was noted within a linear collection of
papules in the left popliteal fossa (Figure 4). A biopsy of
the papule conﬁrmed this to represent a nodular basal2 Journal of Skin Cancer
Figure 1: Posterior lower limbs demonstrating segmental linear
plaques of warty papules on a background of less prominent
hyperkeratotic papules and plaques.
Figure 2: Left lateral upper limb demonstrating diﬀuse hyperkera-
totic papules and plaques.
cell carcinoma (Figure 5) surrounded by characteristic
suprabasal acantholysis and dyskeratosis seen in DD (Figures
6 and 7).
3. Discussion
WepresentacaseofDDwithwell-deﬁnedsegmentalinvolve-
ment superimposed on a milder, diﬀuse manifestation. The
DDcaseisunusualduetoboththedistributionofthedisease
as well as the presence of basal cell carcinoma (BCC).
Over 50 cases of segmental DD have been reported in
the last 100 years and have been variably referred to as
localized, zosteriform, linear, segmental, or unilateral. In
1997, Happle proposed a categorization of mosaic forms of
autosomal dominant skin disorders [3] that includes two
forms of segmental DD. Type 1 segmental manifestation
presents as distinct lesions of equal severity to a nonmosaic
presentation on a background of normal skin. It is believed
thattype1representsanearlypostzygoticmutationresulting
in heterozygosity. The type 2 segmental form manifests as
well-deﬁned areas of DD occurring on the background of
a less severe nonmosaic phenotype. The segmental areas of
involvementcanpresentunilaterallyorascoexistingbandsof
eitherexcessiveorabsentinvolvement.Thislatterphenotypic
presentation is a result of twin spotting. Our patient’s
presentation is consistent with the type 2 segmental form.
Genetically,type2segmentalDDisaresultofaheterozygous
germline mutation compounded by a postzygotic mutation,
such as mitotic recombination, nondisjunction, or deletion
that leads to a homozygous or hemizygous population of
cells for the underlying mutation. To date, 8 cases of type 2
Figure 3: Left thumbnail demonstrating longitudinal erythrony-
chia and distal nicking of the nail plate.
Figure 4: Left popliteal fossa demonstrating a shiny telangiectatic
papule within a linear collection of keratotic papules in the left
popliteal fossa.
segmental DD have been described in the literature [4–11]
(Table 1).
Additionally, this case is unusual due to the presence of
BCC in an area receiving minimal sun exposure. Given the
patient’s young age and the lack of signiﬁcant risk factors
for non-melanoma skin cancer (NMSC), the development
of BCC is unusual and raises suspicion of a link between
DD and cutaneous malignancy. A literature review was
undertaken to identify any association between DD and BCC
or any other cutaneous malignancy. The review revealed that
NMSC occurring in DD has rarely been described. Since
1981, 13 cases of NMSC in patients with DD have been
reported: 7 squamous cell carcinomas (SCC), 5 BCC, and
1 adenexal tumor. Of the 5 cases of BCC, 2 of the cases
had previously received grenz-ray therapy and/or superﬁcial
radiotherapy [12, 13], while no risk factors were associated
with the other 3 cases [13–15]( Table 2).
While no molecular link between DD and BCC has been
described, the imbalance of cellular survival and apoptosisJournal of Skin Cancer 3
Table 1: Summary of the literature search of type 2 segmental cases.
Chester and
Brown [4]
Esche
et al. [5] Happle et al. [6] Itin et al.
[7]
Itin and-Happl
[8]
Yusuf
et al. [9]
de la Torre
Fraga [10]
Rodr´ ıguez-
Pazos et al.
[11]
Presented
A g e 2 5 5 34 5 5 2 1 7 1 22 4 5 0 3 4
Sex Female Male Male Female Male Male Female Male Female
Side of
involvement
and areas of
segmental
distribution
Right side
involving:
Shoulder,
chest,
abdomen,
retroauricu-
lar, and
intraauricular
Face
and
trunk
Left side involving:
retroauricular,
scapular, pectoralis
major, and lumbar
regions
Rightside
involving:
armand
leg
Twin spot
phenomenon
involving: back
N/A N/A Twin spot
phenomenon
Left side
involving:
head, neck,
trunk, and
extremities
Table 2: Summary of the literature review of DD cases with BCC.
Case 1 [12]C a s e 2 [ 14]C a s e 3 [ 13]C a s e 4 [ 13] Case 5
[15] Case 6 Average
Presentation
A g e 4 23 8 4 74 8 3 6 3 4 5 5
Sex Male Male Male Male Female Female M2.1:F1
Tumor and
Site
(a) BCC Leg
(b) BCC Neck
(c) BCC Arm
(a) BCC left
lower eyelid
(b) BCC left
forehead
(a) BCC cheek
(b) Multiple
BCC on face
chest and back
(4 years post-
grenz-rays)
(a)BCCear
(b)BCCscalp
(c)BCC
supraclavicular
fossa
(d)BCCsacrum
BCC
cheek
BCC
popliteal
fossa
70% head
25% trunk
5% penis,
vulva, or
perianal skin
Figure 5: Histopathology of papule in left popliteal fossa consistent
with nodular basal cell carcinoma.
Figure 6: Histopathology demonstrating characteristic Darier’s
pathology of suprabasal acantholysis and dyskeratosis.
Figure 7: Histopathology demonstrating nodular basal cell car-
cinoma surrounded by characteristic suprabasal acantholysis and
dyskeratosis seen in Darier’s disease.
due to the DD mutation or other genodermatosis may
contribute to the presentation. Darier’s disease is caused by
a loss-of-function mutation in the ATP2A2 that leads to
a disruption of Ca2+ homeostasis within the keratinocytes.
A decreased SERCA activity leads to an upregulation of
the transient receptor potential canonical 1Ca channel that
increases cell proliferation and resistance to apoptosis [16].
Additionally, it has been demonstrated that patients with
DD have reduced expression of the antiapoptotic proteins
Bcl-2 and Bcl-XL [17] which may activate apopotosis
and lead to increased cell turnover. Further, alteration of
ATP2A2 gene has been reported in the development of
various other human carcinomas including colon and lung4 Journal of Skin Cancer
cancers [18]. Finally, a genetic predisposition to cancer in
a related genodermatosis, Hailey-Hailey disease, has been
demonstratedin murine models. Speciﬁcally,micewerebred
with a mutated ATP2C1 gene leading to a similar loss in
the golgi Ca2+ pump as in DD. The aged heterozygous mice
demonstrated an increased incidence of malignancy. It was
proposed by Okunade et al. that the loss of the golgi Ca2+
pump lead to Golgi stress and expansion which increased
apoptosis and ultimately causes a genetic predisposition to
cancer [19].
Although the literature is scarce and our understanding
of the relationship between carcinomas and DD is devel-
oping, the case presented illustrates a possible association
between DD and BCC.
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